Enzymatica AB (publ)
Follow Enzymatica AB (publ)

Research See all public content for the subject

Press Releases View all 27 hits

New results from Enzymatica’s in vitro study: ColdZyme also deactivates corona virus

Press Releases   •   Apr 11, 2018 06:45 GMT

Related material

Enzymatica announces a study showing the ability of ColdZyme to deactivate major common cold viruses

Press Releases   •   Nov 14, 2017 12:22 GMT

Enzymatica receives record order from STADA Arzneimittel AG

Press Releases   •   Jun 14, 2017 09:45 GMT

Related material

Enzymatica enters into partnership agreement with STADA Arzneimittel AG

Press Releases   •   Feb 13, 2017 12:15 GMT

Related material

News View all 14 hits

Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus

News   •   May 22, 2018 06:30 GMT

New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness

New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness

News   •   Apr 09, 2018 09:30 GMT

New customer survey – ColdZyme prevents colds and reduces severity and duration among cold sufferers

News   •   Dec 27, 2017 07:45 GMT

ColdZyme study – Most recommended cold product at pharmacies

News   •   Nov 09, 2017 08:00 GMT

Related material

Contacts 3 hits

Carl-Johan Wachtmeister

  • Communication Officer
  • Corporate Communication & Investor Relations
  • cawtrlzdxkphvw-jnjmsohan.wacvqtyhtfpmelgislmter@qnydabenbkeapsrizymatiekmuca.com
  • +46(0) 701 885 021

Jörgen Rexö

  • Senior Communication Officer
  • Corporate Communications
  • jorgentp.rexyfzco@hfenbxguuozymatixfbuymcajcrqoc.com
  • +46(0) 708 19 22 82
  • +46 46 286 31 00

Ulf Blom

Ulf Blom

  • EVP Marketing & Operations
  • ulf.blom@enzymatica.se
  • 0703777328
  • 0462863100